LexaGene introduced in Forbes

by | Dec 5, 2019 | Biologics Manufacturing

Home » Biologics Manufacturing » LexaGene introduced in Forbes

LexaGene was mentioned in this Forbes article as a solution provider tackling the challenge of improving food safety and reducing recalls.

Read the Full Article Here

Food companies are still hampered by the model of sending food test samples to outside labs to check for pathogens, with results coming back in 3-4 days. During that time, some products have already shipped, and if samples come back positive, this could trigger a recall.

LexaGene’s on-site testing analyzer means that food producers can see results in an hour’s time.

<a href="https://lexagene.com/author/lexagene-admin/" target="_self">LexaGene</a>

LexaGene

LexaGene develops fully automated, rapid molecular testing at the point-of-need for accurate pathogen detection in human clinical diagnostics, veterinary diagnostics, food safety, and other markets.

Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology

This spring LexaGene conducted a market research survey in conjunction with AAHA to assess the opinions of practicing veterinarians on AMR stewardship and the use of antibiotics in the treatment of companion animals.

The Dawn of the Superbugs

The most menacing of all resistant bacteria are the so called “super bugs”- strains of bacteria that are resistant to several different classes of antibiotics or multidrug resistant.

LexaGene offers North Shore Technology Council (NSTC) and Leadership Team at MassBio a tour of our Beverly Facility

Recently, we welcomed members of North Shore Technology Council and MassBio Leadership Teams into our facility at 500 Cummings Center for a full tour of our office space and laboratory spaces.

Upcoming Events

No events in this category to show at this time.

Latest Resources


In this study, slow-growing bacterium and typical contaminant, C. acnes, was challenged for microbial detection utilizing both LexaGene’s MiQLab System and anaerobic culture.
1 2 3 4